Assessing Clover Health Investments (CLOV) Valuation After CEO Insider Share Sale Pattern

Simply Wall St.01-10

On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602307189?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063","is_english":true,"pubTime":"2026-01-10 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602307189","market":"hk","top_or_hot":-1,"title":"Assessing Clover Health Investments (CLOV) Valuation After CEO Insider Share Sale Pattern","media":"Simply Wall St.","content":"<div>\n<p>On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch....</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-clov/clover-health-investments/news/assessing-clover-health-investments-clov-valuation-after-ceo\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Clover Health Investments (CLOV) Valuation After CEO Insider Share Sale Pattern</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Clover Health Investments (CLOV) Valuation After CEO Insider Share Sale Pattern\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-10 06:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-clov/clover-health-investments/news/assessing-clover-health-investments-clov-valuation-after-ceo><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch....</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-clov/clover-health-investments/news/assessing-clover-health-investments-clov-valuation-after-ceo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLOV","symbol_name":"Clover Health Corp","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-clov/clover-health-investments/news/assessing-clover-health-investments-clov-valuation-after-ceo","article_id":"2602307189","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice1-main-header/1585187559063"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-clov/clover-health-investments/news/assessing-clover-health-investments-clov-valuation-after-ceo","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602307189","pubTimestamp":1767997488,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch.\nSee our latest analysis for Clover Health Investments.\nClover Health Investments’ share price, which last closed at US$2.53, has seen a 7.7% 7 day share price return and a 5.0% year to date share price return. Its 1 year total shareholder return reflects a 30.5% loss, suggesting recent momentum...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLOV":"Clover Health Corp","PEGI":"Pattern Energy Group Inc.","BK4154":"管理型保健护理","BK4547":"WSB热门概念"},"translate_title":"在首席执行官内幕股票出售模式后评估Clover Health Investments(CLOV)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLOV":1.5,"PEGI":1.5},"content_text":"On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch. See our latest analysis for Clover Health Investments. Clover Health Investments’ share price, which last closed at US$2.53, has seen a 7.7% 7 day share price return and a 5.0% year to date share price return. Its 1 year total shareholder return reflects a 30.5% loss, suggesting recent momentum contrasts with a weaker longer term outcome. If this kind of mixed performance has you rethinking your watchlist, it could be a good moment to scan other healthcare stocks that might better match your risk and return preferences. So with a 30.5% 1 year total return loss, a 104% 3 year gain, and shares trading below the average analyst price target, is Clover Health quietly undervalued, or is the market already pricing in all the growth it sees ahead? AdvertisementMost Popular Narrative: 21.8% Undervalued With Clover Health Investments last closing at US$2.53 versus an estimated fair value of about US$3.23, the most followed narrative sees a meaningful gap that hinges on how fully the business can convert its Medicare Advantage footprint and technology platform into sustainable earnings.  The company's differentiated technology-driven care model, particularly the Clover Assistant platform, positions it to benefit from the healthcare industry's accelerated shift toward technology adoption and data-driven, value-based care, supporting lower medical costs and higher medical margins, with positive implications for both revenue growth and net margins.  Read the complete narrative. Curious what kind of revenue run rate and margin profile need to materialise for that valuation to make sense? The narrative leans on rapid top line expansion, a swing from losses to positive earnings, and a rich future earnings multiple that is more often seen in high growth sectors than in traditional insurers. Result: Fair Value of $3.23 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this upside case still depends on keeping medical cost ratios in check and on Medicare Advantage reimbursement rules remaining supportive, rather than turning into a drag. Find out about the key risks to this Clover Health Investments narrative.  Build Your Own Clover Health Investments Narrative If you see the numbers differently or prefer to test your own assumptions, you can build a custom view in just a few minutes, starting with Do it your way. A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Clover Health Investments. Ready for more investment ideas? If Clover Health has you rethinking your watchlist, do not stop here. Use focused stock lists to pressure test your next idea before you commit capital.  Target potential mispricings by scanning these 878 undervalued stocks based on cash flows that may offer a more compelling entry point than what is already on your radar. Ride long term technology shifts by checking out these 28 AI penny stocks that sit at the intersection of software, data and market scale. Go off the beaten path by reviewing these 79 cryptocurrency and blockchain stocks that tie listed businesses to blockchain and digital asset themes.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602307189","isCrawlerRequest":true}